Moradkhani Asra, Azami Mobin, Mohammadzadeh Pardis, Baradaran Hamid Reza, Saed Lotfolah, Asvad Kianush, Kakaei Rojina, Khateri Sorour, Moradpour Farhad, Moradi Yousef
Student of the Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Department of Epidemiology and Biostatistics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
BMC Endocr Disord. 2025 Jul 1;25(1):149. doi: 10.1186/s12902-025-01959-4.
Given the high prevalence, incidence, and impact on Disability-Adjusted Life Years (DALYs) associated with diabetes, coupled with the limited availability of meta-analysis studies examining its prevalence in the Eastern Mediterranean Regional Office (EMRO) countries, the main objective of this study was to investigate the combined prevalence of type 1 (T1DM) and type 2 diabetes (T2DM), gestational diabetes, and pre-diabetes within the Eastern Mediterranean region.
To implement a comprehensive search strategy aligned with the objectives of this meta-analysis, searches were conducted across international databases, including PubMed (Medline), Scopus, Embase, Web of Science, and the Cumulative Index to Nursing and Allied Health Literature (CINHAL) from January 1967 to December 2022. The quality of the selected studies was assessed using the JBI critical appraisal checklist for analytical cross-sectional studies. Subgroup analyses were conducted based on factors such as gender, country, geographic area, criteria for diagnosis, and Gross Domestic Product (GDP) level.
Out of 5,238 primary studies initially screened, 186 articles were included in the meta-analysis. The pooled prevalence of diabetes was found to be 15% (95% CI: 13 - 16%), of which 6% (95% CI: 4 - 7%) represented undiagnosed cases, while 8% (95% CI: 7 - 10%) were known cases. The prevalence of T2DM was 13% (95% CI: 11 - 16%), while T1DM was found to have a prevalence of 1% (95% CI: 1 - 2%). Pre-diabetes had a pooled prevalence of 15% (95% CI: 13 - 18%), with impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG) representing 9% (95% CI: 7 - 11%) and 8% (95% CI: 6 - 11%) of cases, respectively. The prevalence of gestational diabetes mellitus (GDM) was found to be 11% (95% CI: 9 - 14%) in the EMRO.
The findings emphasize the need for enhanced healthcare programs, including early screening, effective management, and lifestyle interventions such as healthy eating and physical activity. The analysis also highlights the importance of considering socioeconomic factors like urbanization, diet changes, and healthcare access when developing diabetes prevention and management strategies. The results call for policymakers and healthcare providers to collaborate in addressing the growing public health burden of diabetes in the region.
鉴于糖尿病的高患病率、发病率及其对伤残调整生命年(DALYs)的影响,再加上对东地中海区域办事处(EMRO)国家糖尿病患病率进行meta分析的研究有限,本研究的主要目的是调查东地中海区域1型糖尿病(T1DM)、2型糖尿病(T2DM)、妊娠期糖尿病和糖尿病前期的合并患病率。
为实施与本meta分析目标一致的全面检索策略,我们检索了1967年1月至2022年12月期间的国际数据库,包括PubMed(Medline)、Scopus、Embase、Web of Science以及护理学与健康相关文献累积索引(CINHAL)。使用JBI分析性横断面研究的批判性评价清单对所选研究的质量进行评估。基于性别、国家、地理区域、诊断标准和国内生产总值(GDP)水平等因素进行亚组分析。
在最初筛选的5238项初步研究中,有186篇文章纳入meta分析。发现糖尿病的合并患病率为15%(95%CI:13 - 16%),其中6%(95%CI:4 - 7%)为未诊断病例,而8%(95%CI:7 - 10%)为已知病例。T2DM的患病率为13%(95%CI:11 - 16%),而T1DM的患病率为1%(95%CI:1 - 2%)。糖尿病前期的合并患病率为15%(95%CI:13 - 18%),糖耐量受损(IGT)和空腹血糖受损(IFG)分别占病例的9%(95%CI:7 - 11%)和8%(95%CI:6 - 11%)。在EMRO中,妊娠期糖尿病(GDM)的患病率为11%(95%CI:9 - 14%)。
研究结果强调需要加强医疗保健项目,包括早期筛查、有效管理以及健康饮食和体育活动等生活方式干预。分析还强调在制定糖尿病预防和管理策略时考虑城市化、饮食变化和医疗保健可及性等社会经济因素的重要性。结果呼吁政策制定者和医疗保健提供者合作应对该地区日益增长的糖尿病公共卫生负担。